LFST vs LIVN: fair value comparison
LifeStance Health Group, Inc. and LivaNova PLC · Updated 2026-10-19
LFST is still awaiting a full valuation verdict under our six-validated-windows standard. Within Healthcare, LFST currently ranks higher by quality score.
| LFST | LIVN | |
|---|---|---|
| Verdict | Awaiting full valuation | Fairly valued |
| Last price | $11.74 | $77.58 |
| 12-month range | $4.81–$13.38 | $49.57–$85.33 |
| Rank by discount to fair value | — | #53 of 108 Healthcare |
| Rank by quality score | #40 of 301 Healthcare | #41 of 301 Healthcare |
| Quality grade | A | A |
| Leverage | Low | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: LFST fair value analysis · LIVN fair value analysis